The Brady Urological Institute
Liang Dong has not added Biography.
If you are Liang Dong and would like to personalize this page please email our Author Liaison for assistance.
What have genetically engineered mice taught us about ischemic injury?
Current molecular medicine Mar, 2004 | Pubmed ID: 15032714
Functional identification of neuroprotective molecules.
PloS one Nov, 2010 | Pubmed ID: 21124846
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature genetics May, 2017 | Pubmed ID: 28346442
Recent advances in extracellular vesicle research for urological cancers: From technology to application.
Biochimica et biophysica acta. Reviews on cancer 04, 2019 | Pubmed ID: 30738098
A survey of trace metal burdens in increment cores from eastern cottonwood (Populus deltoides) across a childhood cancer cluster, Sandusky County, OH, USA.
Chemosphere Jan, 2020 | Pubmed ID: 31425869
Re: Identification and Characterization of Circulating Tumor Cells in Men Who Have Undergone Prostatectomy of Clinically Localized, High Risk Prostate Cancer.
European urology 02, 2020 | Pubmed ID: 31477346
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer.
European urology oncology 04, 2021 | Pubmed ID: 31563523
The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer.
BJU international 07, 2020 | Pubmed ID: 32115854
Extracellular vesicle isolation from human renal cancer tissue.
Medical oncology (Northwood, London, England) Mar, 2020 | Pubmed ID: 32172294
Prospective evaluation of Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA level.
Medical oncology (Northwood, London, England) Sep, 2020 | Pubmed ID: 32920666
Analysis of the Circulating Tumor Cell Capture Ability of a Slit Filter-Based Method in Comparison to a Selection-Free Method in Multiple Cancer Types.
International journal of molecular sciences Nov, 2020 | Pubmed ID: 33261132
Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium.
Journal of extracellular vesicles 12, 2020 | Pubmed ID: 33489012
High-Throughput Simultaneous mRNA Profiling Using nCounter Technology Demonstrates That Extracellular Vesicles Contain Different mRNA Transcripts Than Their Parental Prostate Cancer Cells.
Analytical chemistry 03, 2021 | Pubmed ID: 33596381
Understanding the tumor-immune microenvironment in prostate cancer.
Current opinion in oncology 05, 2021 | Pubmed ID: 33606403
Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma.
Journal for immunotherapy of cancer 04, 2021 | Pubmed ID: 33820822
Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single-particle analysis platforms.
Journal of extracellular vesicles 04, 2021 | Pubmed ID: 33850608
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Feb, 2022 | Pubmed ID: 34326128
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
Medical oncology (Northwood, London, England) Jul, 2021 | Pubmed ID: 34331598
The role of liquid biopsies in prostate cancer management.
Lab on a chip 09, 2021 | Pubmed ID: 34346466
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer.
Cancer research 12, 2021 | Pubmed ID: 34645612
Advancements in the identification of EV derived mRNA biomarkers for liquid biopsy of clear cell renal cell carcinomas.
Urology Nov, 2021 | Pubmed ID: 34793840
Chi-Ju Kim*,1,2,
Morgan D. Kuczler*,1,
Liang Dong1,3,
Junyoung Kim2,4,
Sarah R. Amend1,
Yoon-Kyoung Cho2,4,
Kenneth J. Pienta1
1The Brady Urological Institute, Johns Hopkins University School of Medicine,
2Department of Biomedical Engineering, School of Life Sciences, Ulsan National Institute of Science and Technology (UNIST),
3Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine,
4Center for Soft and Living Matter, Institute for Basic Science (IBS)
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved